RNS Number : 1118K
Yourgene Health PLC
22 August 2023
 

 

 

 

TR-1: Standard form for notification of major holdings

 

Text Box: NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

 

Yourgene Health plc

Non-UK issuer


2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments


An event changing the breakdown of voting rights


Other (please specify) iii:


3. Details of person subject to the notification obligation iv

Name

Alexander Milne

City and country of registered office (if applicable)


4. Full name of shareholder(s) (if different from 3.) v

Name

IG Trading & Investments Ltd Interactive Investor Services Ltd

City and country of registered office (if applicable)

London, UK Leeds, UK

5. Date on which the threshold was crossed or reached vi:

17/08/2023

6.

18/08/2023

7. Total positions of person(s) subject to the notification obligation


% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments

(total of 8.B 1 + 8.B 2)

 

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A +

8.B) vii

Resulting situation on the date on which threshold was crossed or reached

 

5.46%


 

5.46%

 

174,500,000


 

 

 

Position of previous notification (if applicable)

 

  4.29%


 

  4.29%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type of shares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

GB00BN31ZD89.

174,500,000


5.46%












SUBTOTAL 8. A

174,500,000

5.46%


B 1: Financial Instruments according to DTR5.3.1R (1) (a)

 

Type of financial instrument

 

Expiration date x

 

Exercise/ Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

 

% of voting rights

















SUBTOTAL 8. B 1




B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expiration date x

Exercise/ Conversion

Period xi

Physical or cash

Settlement xii

Number of voting rights

 

% of voting rights




















SUBTOTAL 8.B.2





 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii


Full chain of controlled undertakings through which the voting rights and/or the

financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv


 

 

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the

notifiable threshold

Total of both if it equals or is higher than the notifiable threshold





















 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder


The number and % of voting rights held


The date until which the voting rights will be held


 

 


 

Place of completion

UK

Date of completion

18/08/2023

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLPTMTTMTBTBBJ